Jang-Hee Hong (Jang Hee Hong)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 17

Top Topics

Computed Tomography

Postmenopausal Women

Top Venues

Translational and clinical pharmacology

Advances in therapy

Expert opinion on biological therapy

Molecular genetics & genomic medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jae Hoon Kim, Ji Hye Song, MinYoung Kim, Jang-Hee Hong, Jung Sunwoo, Jin Gyu Jung
Pharmacokinetic Comparison of a Fixed-Dose Combination of Candesartan Cilexetil/Amlodipine/Atorvastatin Versus Co-administration of Individual Formulations in Healthy Participants. Advances in therapy 41 (7) (2024)
Anhye Kim, Jang-Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy 24 (7) (2024)
Anhye Kim, Jang-Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy (2024)
Jae Hoon Kim, Ji Hye Song, MinYoung Kim, Jang-Hee Hong, Jung Sunwoo, Jin Gyu Jung
Pharmacokinetic Comparison of a Fixed-Dose Combination of Candesartan Cilexetil/Amlodipine/Atorvastatin Versus Co-administration of Individual Formulations in Healthy Participants. Advances in therapy 41 (7) (2024)
Jae Hoon Kim, Ji Hye Song, MinYoung Kim, Jang-Hee Hong, Jung Sunwoo, Jin Gyu Jung
Pharmacokinetic Comparison of a Fixed-Dose Combination of Candesartan Cilexetil/Amlodipine/Atorvastatin Versus Co-administration of Individual Formulations in Healthy Participants. Advances in therapy (2024)
Anhye Kim, Jang-Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy 24 (7) (2024)
Jae Hoon Kim, Ji Hye Song, MinYoung Kim, Jang-Hee Hong, Jung Sunwoo, Jin Gyu Jung
Pharmacokinetic Comparison of a Fixed-Dose Combination of Candesartan Cilexetil/Amlodipine/Atorvastatin Versus Co-administration of Individual Formulations in Healthy Participants. Advances in therapy 41 (7) (2024)
Anhye Kim, Jang-Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy (2024)
Anhye Kim, Jang-Hee Hong, Wonsuk Shin, Hyounggyoon Yoo, Jin Gyu Jung, Jean-Yves Reginster, SungHyun Kim, YunJu Bae, JeeHye Suh, Sera Kim, EunKyung Lee, Stuart L Silverman
A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males. Expert opinion on biological therapy 24 (7) (2024)
Yu-Bin Seo, Jae Hoon Kim, Ji Hye Song, WonTae Jung, Kyu-Yeol Nam, Nyung Kim, Youn-Woong Choi, SangMin Cho, Do-Hyung Ki, Hye Jung Lee, JungHa Moon, SeungSeob Lee, JaeHee Kim, Jang-Hee Hong, Jung Sunwoo, Jin Gyu Jung
Safety and pharmacokinetic comparison between fenofibric acid 135 mg capsule and 110 mg enteric-coated tablet in healthy volunteers. Translational and clinical pharmacology 31 (2) (2023)
Hyun Chul Kim, Deok Yong Yoon, Seung Hwan Lee, In-Jin Jang, Jang-Hee Hong, Jae Woo Kim
Comparative pharmacokinetics between two tablets of tramadol 37.5 mg/acetaminophen 325 mg and one tablet of tramadol 75 mg/acetaminophen 650 mg for extended-release fixed-dose combination. Translational and clinical pharmacology 30 (2) (2022)
Yewon Park, WonTae Jung, Eunsol Yang, Kyu-Yeol Nam, Woo-Ri Bong, JaeHee Kim, Kyu Yeon Kim, Seung Hwan Lee, Joo-Youn Cho, Jang-Hee Hong, Jae Woo Kim
Evaluation of food effects on the pharmacokinetics of Pelargonium sidoides and Coptis with each bioactive compound berberine and epicatechin after a single oral dose of an expectorant and antitussive agent UI026 in healthy subjects. Translational and clinical pharmacology 30 (1) (2022)
Jae Hoon Kim, Minyu Lee, Namsick Kim, Tae-Young Oh, Seung-Kwan Nam, Yoon Seok Choi, In Sun Kwon, Jin Gyu Jung, Jang-Hee Hong
Comparison of pharmacokinetics and safety characteristics between two olopatadine hydrochloride 5 mg tablet formulations in healthy Korean subjects. Translational and clinical pharmacology 29 (1) (2021)
Jang-Hee Hong, Eun-Heui Jin, In Ae Chang, Hyojin Kang, Sang-Il Lee, Jae Kyu Sung
Association of long noncoding RNA MALAT1 polymorphisms with gastric cancer risk in Korean individuals. Molecular genetics & genomic medicine 8 (12) (2020)
Ji-Sun Yeun, Hye-Su Kan, Minyu Lee, Namsick Kim, Tae-Young Oh, Seung-Kwan Nam, Yoon Seok Choi, In Sun Kwon, Jang-Hee Hong
Pharmacokinetic comparison of two bazedoxifene acetate 20 mg tablet formulations in healthy Korean male volunteers. Translational and clinical pharmacology 28 (2) (2020)
Jang-Hee Hong, Eun-Heui Jin, In Ae Chang, Hyojin Kang, Sang-Il Lee, Jae Kyu Sung
Association Between lncRNA HULC rs7763881 Polymorphism and Gastric Cancer Risk. Pharmacogenomics and personalized medicine 13 (2020)
SeungHwan Lee, Jun Gi Hwang, Sang Yeob Park, Hye Jung Lim, Sa-Won Lee, Min-Hyo Seo, JaeWoo Kim, Jang-Hee Hong
Single-Dose Comparative Pharmacokinetics of Two Formulations of Lenalidomide 25 mg in Healthy Subjects: A Randomized Crossover Study. Advances in therapy 35 (2) (2018)
Young Ok Baik, Seuk Keun Choi, Jae Woo Kim, Jae Seung Yang, Ick Young Kim, Chan Wha Kim, Jang-Hee Hong
Safety and immunogenicity assessment of an oral cholera vaccine through phase I clinical trial in Korea. Journal of Korean medical science 29 (4) (2014)